Patent №
US 8,718,341
Granted
2014-05-06
Filed 2011
Owner
KONINKLIJKE PHILIPS ELECTRONICS N. V.
Lab
—
AI components
2
ml · vision
Assignment
Recorded
Dataset
AIPD
2023_r1 edition
Application
13131140
When characterizing a tumor or lesion as malignant or benign, a system (10) receives an image of the lesion volume (50), employs a processor (12) to perform a raw segmentation of the image, the results of which are stored to memory (14). Then processor then executes a hole-filling procedure to fill in dark areas in the image of the lesion representing necrotic tissue that absorbed little or no contrast agent, and optionally a leakage removal procedure to remove image voxels associated with non-lesion tissue, e.g., blood vessels, in which the contrast agent was present during imaging, to generate a complete lesion volume. A voxel analyzer (18) assesses a number of voxels included in the raw segmentation of the lesion image, and the final segmentation (e.g., after filling and optional leakage removal). A segmentation comparator (20) computes a ratio of dark area voxels related to necrotic tissue detected after the raw segmentation to total voxels detected in the final image segmentation. The ratio is then used to determine a likelihood of malignancy, with a higher ratio indicating a higher likelihood.
AI classification
Ownership
KONINKLIJKE PHILIPS ELECTRONICS N. V.
assignment · 263410273
Assignors
BUELOW, THOMAS, WIEMKER, RAFAEL, BERGTHOLDT, MARTIN, MEINEL, LINA ARBASH
On an employer assignment, the assignors are typically the inventors.